This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ONEV
Can Willis Towers (WTW) Pull Off a Surprise in Q2 Earnings?
by Zacks Equity Research
Willis Towers' (WTW) second-quarter results are likely to reflect the impact of increased demand for advisory work, new business in North America, increased retention, technology sales and lower expenses.
Will Arthur J. Gallagher (AJG) Beat Q2 Earnings Estimates?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) second-quarter results are expected reflect benefits from new business, strong retention and renewal premium increases across its business lines.
Aon (AON) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Aon (AON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Should You Stay Invested in Willis Towers (WTW) Stock
by Zacks Equity Research
Segmental strength, solid capital position and favorable growth estimates make Willis Towers (WTW) stock worth retaining in one's portfolio.
Willis Towers Watson (WTW) Moves 3.6% Higher: Will This Strength Last?
by Zacks Equity Research
Willis Towers Watson (WTW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Here's Why Hold is an Apt Strategy for Willis Towers (WTW)
by Zacks Equity Research
Segmental strength, solid capital position and favorable growth estimates make Willis Towers (WTW) stock worth retaining in one's portfolio.
Zacks Industry Outlook Highlights Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Tower Watson, and Brown & Brown
by Zacks Equity Research
Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Tower Watson, and Brown & Brown are part of Zacks Industry Outlook article.
5 Insurance Brokers Benefiting From Rising Demand
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials and the adoption of technology should drive insurance brokers like MMC, AON, AJG, WTW and BRO.
Arthur J. Gallagher (AJG) Q1 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Arthur J. Gallagher (AJG) Q1 results reflect higher revenues across Brokerage and Risk Management segments, partially offset by higher expenses.
Willis Towers (WTW) Q1 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Willis Towers (WTW) Q1 results reflect solid performance of the Health, Wealth & Career segment, which was offset by softness in Risk & Broking.
Willis Towers Watson (WTW) Q1 Earnings Top Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 5.98% and 4.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q1 Earnings on Apr 28: CINF, FAF & More
by Zacks Equity Research
Solid retention, exposure growth, favorable renewals, compelling products and service portfolio and adoption of technologies are likely to aid the insurers' first-quarter results. CINF, FAF, HIG, AJG & WTW are set to report results on Apr 28.
Brown & Brown (BRO) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Brown & Brown (BRO) delivered earnings and revenue surprises of 4% and 1.36%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers (WTW) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Willis Towers' (WTW) first-quarter revenues are likely to have witnessed the impact of increased demand for advisory services, new business activity, strong renewals, technology sales, growth in Medicare Advantage and Life sales.
Analysts Estimate Willis Towers Watson (WTW) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Willis Towers Watson (WTW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Willis Towers Watson (WTW) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Stay Invested in Willis Towers (WTW)
by Zacks Equity Research
Segmental strength, solid capital position and favorable growth estimates make Willis Towers (WTW) stock worth retaining in one's portfolio.
Willis Towers Watson (WTW) Down 1.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Willis Towers Watson (WTW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Willis Towers (WLTW) Q4 Earnings Top Estimates, Revenues Lag
by Zacks Equity Research
Willis Towers (WLTW) Q4 results reflect solid performance of the Human Capital and Benefits (HCB) segment, Investment, Risk & Reinsurance, and Benefits Delivery & Administration, which was offset by softness in Corporate Risk & Broking.
Willis Towers Watson (WTW) Q4 Earnings Beat Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 5.98% and 3.35%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks Q4 Earnings on Feb 8: AIZ, WTW and More
by Tanuka De
Better pricing, exposure growth, solid retention, favorable renewals, reinsurance agreements, and accelerated digitalization likely have favored fourth-quarter results of AIZ, WTW, CNO and VOYA.
Will Willis Towers (WTW) Retain Its Beat Streak in Q4 Earnings?
by Zacks Equity Research
Willis Towers (WLTW) fourth-quarter results are likely to reflect the impact of growth in Medicare Advantage and Life sales, strong renewals and new business activity.
What's in the Cards for CME Group (CME) in Q4 Earnings?
by Zacks Equity Research
CME Group's (CME) fourth-quarter performance is likely to have been aided increased trading activity and lower costs.
Why Willis Towers Watson (WTW) Might Surprise This Earnings Season
by Zacks Equity Research
Willis Towers Watson (WTW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.